Continued hCG surveillance following chemotherapy for gestational trophoblastic neoplasia: When is enough enough?
Gynecol Oncol
.
2019 Oct;155(1):1-2.
doi: 10.1016/j.ygyno.2019.09.006.
Authors
Kevin M Elias
1
,
Ross S Berkowitz
1
,
Neil S Horowitz
1
Affiliation
1
New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115 USA.
PMID:
31601360
DOI:
10.1016/j.ygyno.2019.09.006
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Chorionic Gonadotropin
Female
Gestational Trophoblastic Disease*
Humans
Pregnancy
Substances
Chorionic Gonadotropin